Jamshid Sorouri Khorashad, Simon Wagner, Liat Greener, David Marin, Alistair Reid, Dragana Milojkovic, Hetal Patel, Shaun Willimott, Katy Rezvani, Gareth Gerrard, Sandra Loaiza, John Davis, John Goldman, Junia Melo, Jane Apperley, Letizia Foroni. The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib. haematol [Internet]. 2009May29 [cited 2024Nov.23];94(6):861-4. Available from: https://haematologica.org/article/view/5278